Breakthrough £90,000 Alzheimer’s drugs unlikely to benefit patients, report suggests

A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

About the Author

has written 41952 stories on this site.

Copyright © 2010 Business and Corporate News.